Citations are updated once a week. Recently added citations may not appear.
The suggestion is based on each study and bacteria having different weight based on a multitude of factors. For example, how severe a shift is seen.
| Context | Citation |
|---|---|
| Increases Escherichia coli PMV-1 - : D-ribofuranoside {Ribose} |
👶
L-fucose stimulates utilization of D-ribose by Escherichia coli MG1655 DeltafucAO and E. coli Nissle 1917 DeltafucAO mutants in the mouse intestine and in M9 minimal medium. Infection and immunity (Infect Immun ) Vol: 75 Issue 11 Pages: 5465-75 Pub: 2007 Nov Epub: 2007 Aug 20 Authors Autieri SM , Lins JJ , Leatham MP , Laux DC , Conway T , Cohen PS , Html Article Publication |
| Increases Escherichia coli PMV-1 - : D-ribofuranoside {Ribose} |
👶
D-ribose metabolism in Escherichia coli K-12: genetics, regulation, and transport. Journal of bacteriology (J Bacteriol ) Vol: 158 Issue 2 Pages: 665-73 Pub: 1984 May Epub: Authors Lopilato JE , Garwin JL , Emr SD , Silhavy TJ , Beckwith JR , Publication |
| Increases Escherichia coli PMV-1 - : D-ribofuranoside {Ribose} |
👶
Involvement of the ribose operon repressor RbsR in regulation of purine nucleotide synthesis in Escherichia coli. FEMS microbiology letters (FEMS Microbiol Lett ) Vol: 344 Issue 2 Pages: 159-65 Pub: 2013 Jul Epub: 2013 Jun 3 Authors Shimada T , Kori A , Ishihama A , Publication |
| 0 😁 | 😢 0 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
